Werewolf Therapeutics

IPO

Home Page | Werewolf Therapeutics Inc.

Public · Watertown, United States · Founded 2017 · $206.0M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$206.0M
Last Round
$150.0M Growth EquityAug 2026
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Werewolf Therapeutics is a clinical-stage biotechnology company founded in 2017 by Dan Hicklin, focused on developing a novel class of conditionally activated proinflammatory immune modulators—called WEREs (Agonists Regulated by the Environment)—that act selectively within the tumor microenvironment to treat cancer. The company's pipeline targets solid tumors and hematologic malignancies using its proprietary PREDATOR platform, which engineers cytokines and other immune-activating proteins to remain inert in healthy tissue while potently activating within tumors. Werewolf Therapeutics is publicly traded on Nasdaq under the ticker HOWL and is headquartered in the greater Boston, Massachusetts area.

Summary

Werewolf Therapeutics is a Biotech company based in Watertown, United States, founded in 2017. It has raised $206.0M in total across 2 rounds, most recently a $150.0M Growth Equity round in Aug 2026. Investors include MPM Capital, Longwood Fund and Taiho Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Growth EquityGrowth EquityAug 2026
$150.0M

Sign up to see all 3 events

Funding: Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Werewolf Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/werewolf-therapeutics"><img src="https://indexed.vc/api/badge/company/werewolf-therapeutics" alt="Werewolf Therapeutics on Indexed.vc" width="260" height="76" /></a>